The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Dec 11

PMID 36497384

Authors

Asia Marangio

Andrea Biccari

Edoardo DAngelo

Francesca Sensi

Gaya Spolverato

Salvatore Pucciarelli

Marco Agostini

Affiliations

Soon will be listed here.

Abstract

Bidirectional communication between cells and their microenvironment has a key function in normal tissue homeostasis, and in disease initiation, progression and a patient's prognosis, at the very least. The extracellular matrix (ECM), as an element of all tissues and cellular microenvironment, is a frequently overlooked component implicated in the pathogenesis and progression of several diseases. In the inflammatory microenvironment (IME), different alterations resulting from remodeling processes can affect ECM, progressively inducing cancer initiation and the passage toward a tumor microenvironment (TME). Indeed, it has been demonstrated that altered ECM components interact with a variety of surface receptors triggering intracellular signaling that affect cellular pathways in turn. This review aims to support the notion that the ECM and its alterations actively participate in the promotion of chronic inflammation and cancer initiation. In conclusion, some data obtained in cancer research with the employment of decellularized ECM (dECM) models are described. The reported results encourage the application of dECM models to investigate the short circuits contributing to the creation of distinct IME, thus representing a potential tool to avoid the progression toward a malignant lesion.

Citing Articles

The heat of the battle: inflammation's role in prostate cancer development and inflammation-targeted therapies.

Sharma U, Sahu A, Shekhar H, Sharma B, Haque S, Kaur D Discov Oncol. 2025; 16(1):108.

PMID: 39891849 PMC: 11787145. DOI: 10.1007/s12672-025-01829-4.

The Role of Pericytes in Inner Ear Disorders: A Comprehensive Review.

Maniaci A, Briglia M, Allia F, Montalbano G, Romano G, Zaouali M Biology (Basel). 2024; 13(10).

PMID: 39452111 PMC: 11504721. DOI: 10.3390/biology13100802.

Identification of TIMP1-induced dysregulation of epithelial-mesenchymal transition as a key pathway in inflammatory bowel disease and small intestinal neuroendocrine tumors shared pathogenesis.

Tran M Front Genet. 2024; 15:1376123.

PMID: 39233736 PMC: 11371700. DOI: 10.3389/fgene.2024.1376123.

[ Capsule alleviates interleukin-1β-induced chondrocyte inflammation and extracellular matrix degradation by regulating the miR-502-5p/TRAF2/NF-κB axis].

Zhou Q, Liu J, Wan L, Zhu Y, Qi Y, Hu Y Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(1):108-118.

PMID: 38293982 PMC: 10878885. DOI: 10.12122/j.issn.1673-4254.2024.01.13.

Expression of Stemness Markers in the Cervical Smear of Patients with Cervical Insufficiency.

Pittokopitou S, Mavrogianni D, Pergialiotis V, Pappa K, Antsaklis P, Theodora M Cells. 2023; 12(8).

PMID: 37190092 PMC: 10137205. DOI: 10.3390/cells12081183.

References

Petrey A, de la Motte C . The extracellular matrix in IBD: a dynamic mediator of inflammation. Curr Opin Gastroenterol. 2017; 33(4):234-238. PMC: 5562400. DOI: 10.1097/MOG.0000000000000368. View

Karsdal M, Nielsen M, Sand J, Henriksen K, Genovese F, Bay-Jensen A . Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol. 2012; 11(2):70-92. PMC: 3593693. DOI: 10.1089/adt.2012.474. View

Nicolas S, Abdellatef S, Haddad M, Fakhoury I, El-Sibai M . Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways. Cells. 2019; 8(11). PMC: 6912653. DOI: 10.3390/cells8111397. View

Gupta R, DuBois R . Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2002; 1(1):11-21. DOI: 10.1038/35094017. View

Schussler M, Skoudy A, Ramaekers F, Real F . Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol. 1992; 140(3):559-68. PMC: 1886166. View

DAngelo E, Natarajan D, Sensi F, Ajayi O, Fassan M, Mammano E . Patient-Derived Scaffolds of Colorectal Cancer Metastases as an Organotypic 3D Model of the Liver Metastatic Microenvironment. Cancers (Basel). 2020; 12(2). PMC: 7072130. DOI: 10.3390/cancers12020364. View

Egeblad M, Nakasone E, Werb Z . Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18(6):884-901. PMC: 2905377. DOI: 10.1016/j.devcel.2010.05.012. View

Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

Muncie J, Weaver V . The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate. Curr Top Dev Biol. 2018; 130:1-37. PMC: 6586474. DOI: 10.1016/bs.ctdb.2018.02.002. View

10.

Kai F, Drain A, Weaver V . The Extracellular Matrix Modulates the Metastatic Journey. Dev Cell. 2019; 49(3):332-346. PMC: 6527347. DOI: 10.1016/j.devcel.2019.03.026. View

11.

Iwabuchi K, Nagaoka I, Someya A, Yamashita T . Type IV collagen-binding proteins of neutrophils: possible involvement of L-selectin in the neutrophil binding to type IV collagen. Blood. 1996; 87(1):365-72. View

12.

Albrengues J, Bertero T, Grasset E, Bonan S, Maiel M, Bourget I . Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nat Commun. 2015; 6:10204. PMC: 4682161. DOI: 10.1038/ncomms10204. View

13.

Noble P, Horton M, Bao C, Wysoka M, Burdick M, Strieter R . Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol. 1997; 159(5):2492-500. View

14.

Kapalczynska M, Kolenda T, Przybyla W, Zajaczkowska M, Teresiak A, Filas V . 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch Med Sci. 2018; 14(4):910-919. PMC: 6040128. DOI: 10.5114/aoms.2016.63743. View

15.

White E, Muro A . Fibronectin splice variants: understanding their multiple roles in health and disease using engineered mouse models. IUBMB Life. 2011; 63(7):538-46. DOI: 10.1002/iub.493. View

16.

Shimshoni E, Adir I, Afik R, Solomonov I, Shenoy A, Adler M . Distinct extracellular-matrix remodeling events precede symptoms of inflammation. Matrix Biol. 2020; 96:47-68. DOI: 10.1016/j.matbio.2020.11.001. View

17.

Horton M, Olman M, Bao C, White K, Choi A, Chin B . Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol. 2000; 279(4):L707-15. DOI: 10.1152/ajplung.2000.279.4.L707. View

18.

Chetram M, Bethea D, Odero-Marah V, Don-Salu-Hewage A, Jones K, Hinton C . ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells. Mol Cell Biochem. 2013; 376(1-2):63-71. PMC: 3578043. DOI: 10.1007/s11010-012-1549-7. View

19.

Wang J, Li D, Cang H, Guo B . Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. Cancer Med. 2019; 8(10):4709-4721. PMC: 6712467. DOI: 10.1002/cam4.2327. View

20.

Khan K, Falcone D . Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J Biol Chem. 1997; 272(13):8270-5. DOI: 10.1074/jbc.272.13.8270. View